The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I/II study of cisplatin and radiation in combination with sorafenib in cervical cancer: Evaluation of biomarkers.
C. A. Townsley
No relevant relationships to disclose
M. Milosevic
No relevant relationships to disclose
M. A. Haider
No relevant relationships to disclose
H. Mackay
No relevant relationships to disclose
I. Yeung
No relevant relationships to disclose
S. Kim
No relevant relationships to disclose
W. Levin
No relevant relationships to disclose
L. Manchul
No relevant relationships to disclose
S. Bindra
No relevant relationships to disclose
K. MacAlpine
No relevant relationships to disclose
L. M. Tinker
No relevant relationships to disclose
L. Wang
No relevant relationships to disclose
J. Quintos
No relevant relationships to disclose
A. W. Fyles
No relevant relationships to disclose
A. M. Oza
No relevant relationships to disclose